explore -WSS

explore

author：explore 2025-10-01 10:36:09 - browse：143

Christine Kao/STAT

The Food and Drug Administration’s approval on Friday of two gene therapies for sickle cell disease sets up what could be an intense competition between Bluebird Bio, maker of Lyfgenia, and the partnership of Vertex Pharmaceuticals and CRISPR Therapeutics, whose drug is Casgevy.

For the first time, physicians and patients will have a choice of potentially curative treatments for an inherited disease that affects nearly 100,000 Americans.

The Vertex/CRISPR team would seem to have the edge. As the first CRISPR-based therapy, Casgevy has the advantage of being powered by the latest and buzziest biological technology, though some physicians and patients may be more comfortable with the lentiviral vector technology behind Lyfgenia, which dates back to the 1990s — even with a “black box” warning of a risk of blood cancer added to its label.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Noem? Reynolds? A very early look at the Republican 'veepstakes'

WSS

AstraZeneca loses challenge to Medicare drug price negotiation

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

A timeline of the missing Titanic tourist submersible

Kenai launches with $82 million for Parkinson’s stem cell therapy

focus

explore

focus

Novavax promises a turnaround & Lilly roils the obesity market

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Activists slam private health insurers over coverage restrictions

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

How to save PrEP access — and even expand it

Why getting cancer drugs just got harder for rural patients

Dobbs anniversary: the lost opportunity of abortion as health care

4 dead, 2 in stable condition in Philadelphia shooting: Police

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Scientists unlock the key to scar

hotspot

Flu vaccine offering decent levels of protection this winter, new data show

International team creates first chimeric human

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

In search for therapies for solid tumors, companies turn to claudin

July 4th fireworks can be stressful for dogs. These 6 tips can keep them calm and safe

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

Wikipedia

focus

hotspot

hotspot